GEHC
Earnings season: now with extra balance-sheet drama
GE HealthCare just rolled out its fourth-quarter and full-year 2025 financial update. The big headline for investors isn’t just the revenue/earnings reveal — it’s also the company showing it had $4.5 billion in cash, $3.5 billion in revolving credit access, and $10.0 billion of debt at year-end. That’s a pretty classic “we’re fine, but please keep an eye on the scoreboard” setup.
Dividend? Still here
The company also declared a quarterly dividend of $0.035 per share for stockholders of record for all quarters in 2025. That’s the kind of move income investors like to see because it signals management still wants to return cash even while the business is dealing with the usual corporate soap opera: tariffs, trade restrictions, supply chains, and macro uncertainty.
Why this matters to investors
Earnings updates are where you find out whether the growth story is real or just PowerPoint caffeine. GE HealthCare is telling investors it’s still leaning on normalized profitability metrics like adjusted EBIT and adjusted EPS, which usually means management wants you looking past one-time noise and toward the underlying trend.
The catch? The company is also openly flagging risks around tariffs and other trade restrictions. Translation: if global trade gets messier, the math can get messier too.
Big picture: this looks like a steady-but-still-exposed healthcare hardware name doing its best to keep cash flowing while the macro weather forecast stays cloudy.